| Tag | Content |
|---|
EnhancerAtlas ID | HS091-24471 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr19:48994880-48996950 |
Target genes | | Number: 36 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF16 | MA0741.1 | chr19:48996445-48996456 | GCCCCGCCCCC | + | 6.02 | | KLF16 | MA0741.1 | chr19:48996104-48996115 | ACCACGCCCCC | + | 6.14 | | KLF5 | MA0599.1 | chr19:48996445-48996455 | GCCCCGCCCC | + | 6.02 | | KLF5 | MA0599.1 | chr19:48996526-48996536 | GCCCCGCCCC | + | 6.02 | | KLF5 | MA0599.1 | chr19:48996612-48996622 | GCCCCGCCCC | + | 6.02 | | KLF5 | MA0599.1 | chr19:48996633-48996643 | GCCCCGCCCC | + | 6.02 | | KLF5 | MA0599.1 | chr19:48996645-48996655 | GCCCCGCCCC | + | 6.02 | | KLF5 | MA0599.1 | chr19:48996778-48996788 | GCCCCGCCCC | + | 6.02 | | KLF5 | MA0599.1 | chr19:48996811-48996821 | GCCCCGCCCC | + | 6.02 | | Klf12 | MA0742.1 | chr19:48996744-48996759 | GGCCACGCCCCACTC | + | 6.02 | | Nr2f6(var.2) | MA0728.1 | chr19:48995662-48995677 | CGAACTCTTGACCTC | - | 6.24 | | SP1 | MA0079.4 | chr19:48996442-48996457 | CAGGCCCCGCCCCCG | + | 6.11 | | SP1 | MA0079.4 | chr19:48996101-48996116 | TAGACCACGCCCCCG | + | 6.29 | | SP2 | MA0516.2 | chr19:48996229-48996246 | CCTAGTCCCGCCCCATT | + | 6.08 | | SP4 | MA0685.1 | chr19:48996742-48996759 | CAGGCCACGCCCCACTC | + | 6.08 | | SP4 | MA0685.1 | chr19:48996101-48996118 | TAGACCACGCCCCCGTC | + | 6.33 | | SP4 | MA0685.1 | chr19:48996442-48996459 | CAGGCCCCGCCCCCGCT | + | 6.35 | | Zfx | MA0146.2 | chr19:48995687-48995701 | CCCGCCTCGGCCTC | + | 6.01 | | Zfx | MA0146.2 | chr19:48996442-48996456 | CAGGCCCCGCCCCC | - | 6.19 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_34585 | chr19:48994657-48998131 | HCT-116 | | SE_65829 | chr19:48992785-48995418 | Pancreatic_islets | | SE_65829 | chr19:48995676-48998227 | Pancreatic_islets |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I048489 | chr19 | 48992929 | 48998057 |
|
Enhancer Sequence | TAATATTTCT GGGGCTCTAG GAATCCCAAT TTGTAATCAC TGACTCGCAC GCTCTGGAGA 60
GGTGGCTGGA GCCCCTAATC TGGCTTCGAA GCCTTGGGCC AGCCTTAACC TCAACCTGGC 120
CAGAGGCTCC TTTCCTGACA GCGGAGCCCC GCGCACAGCT AAGTAGCCCA ACGCAGGGAT 180
TCTCTCCTGG CTCATTAACG TGAGGCCTCC ACCGGATCCC CTAACCCAAA GCGATCTCCA 240
TAAGCCCCAC CCCGTCCACG TCAGTCCCAC CCACCTCTGA GATCTTGACC TGCTCCAGTG 300
GCCCTCCCAA CCCCTGCCCC ATCCTGAGCG CATGCCGTGC TGGATGCTGT GACCCTGCCC 360
CTGAGCCCTC CCTCAGAAGT AGACCTGCTC CCGCCCTCCA AGTCCCACCC CTCTGAAAAC 420
ATTTCAGTGG CCCAGGCCCC AGTTCTTGGC CTTGTTTCCA TTCCTTTCAT AATCTCAGCC 480
CAGTATGCCC GCCCCAGGTT CATCTAGACA AGGTCCCAGT TCCTCAGCAC CACTCGCCCT 540
CCCTTTTTCT CTTCAACACC ATATCCTGTG TTTTTCTTTT TGTTTTAGAC AGAGTCTCAC 600
TGTCGCCCAG GCTGGAGAGC AGTGTTGTGA TCATGGCTCA ATGCAGCCTC AACCTCCTGG 660
GCTCAAGCGA TCCTCCCACC TGAGCCTCCT AAGTAGCTGG GACTACAGAT GCGCACCACC 720
ACACCAAGAT AATTTTTTTC TTTTTAAGAG ACGAGGTCTC GCCATTTTGG CTAGGCTGGT 780
CTCGAACTCT TGACCTCAAG TGATCCTCCC GCCTCGGCCT CCCAAAGTGC TGGGATTACA 840
GGCGTGAGCC ACCCGGGACA GGCCTAACTC TTAACACATT CCTCAACCCA TCTCTCTAAA 900
GACCCGTCCC AGTCGTTAGG TTCGCTCATC CCTGACCTCA CCCCAGAATA CGTTAAGACT 960
GCCTGCTCCA TCTCTGAAGC CCACCTGCAG CCTAGCCATG GCCCTTCCCT AGTGGGTAAG 1020
ATCTGCTCCA ACCCGAACCA GCCTACAGAC ACTAGAACTC TAGTCAACAA ACCATGCCCA 1080
AACTCTCACT AGGCCCCTTC ACCATCCAGG CCTCTTCTCA ACACTTCCTC CCTAGCCTCT 1140
CCAGGATCCC ATACTTGACT ACCCAGTACC CCCTCTTTCC TTCCAGACCC ACACTCTCTC 1200
TCCAGACCTC TCCTCGCCCT CTAGACCACG CCCCCGTCAC AAGCCCTGCC CTCACCCTAG 1260
GTCCCGCCCC AGCTCTAGGC TCGGCCCATA CTCCTGGCCC TGCCCCATTG CCAGGCCCTG 1320
CCCTCACACT CAAAGCCTCC TCCCATCTTC CTAGTCCCGC CCCATTTCCC TGACCAGTCT 1380
CTCCCCAGAC CCCGCCTTCA CCCCTCAGGC CCTTCCCGCG CCCTGCTCCA TCCGCCCCGC 1440
CCTAGGCTCC GCCCCCATTC CAGCCTTGGA TTTTCTCCAG GCCTCCTCTT GCCGCGCCAC 1500
AGACTTGGCC TCCCTCAGGC CCGGATCCAG ACTCTGTCCC GATCCTAGGC GCGGTCTCCT 1560
TCCAGGCCCC GCCCCCGCTC TAGGCTCAGC CTGCCTTCAA ACCCTGCTGT AGACCCCGCC 1620
CCACCCTAAG CTCAGCCTTC GTCTAGGCCC CGCCCCAGGC CCTGCACCTC TAGGCTCGAC 1680
CTCCCTCCAG GCCCCGCCCT GGGCTCCGCC CCCCAGCCCG CCCTCTCCCT GGGCCCCGCC 1740
CCACTCTAGC TCGGCCCCGC CCCAGGCCCC GCCCCACTCT AGATTGGGGC TCCCCTTAGG 1800
TCCCACCCCA ATTCAGCTTG CCCTCCCTCC AGGCCCCGCA TCACTCCAGC TCGGCCTCCC 1860
TTCAGGCCAC GCCCCACTCT AACTCGGCCT CCCTCCAGGC CCCGCCCCAC CCTAGCTCGG 1920
CCTCCCTTCA GGCCCCGCCC CACTCCAGCT CCGCCTCCCT CCAGGCCCCG CCCAACTCTA 1980
AGCTCGGCCT CCCGCCAGGC CCTTCCCGGC TCTAGGCTCC TGCTCCCTCC AGGCCGCGAC 2040
CCCGAAACCG CGCCCTCTCG GGTTCCGCAC 2070
|
